Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Gollmer, J; Zirlik, A; Schmidt, A.
New Developments in Mitral and Tricuspid Valve Therapy.
J KARDIOL. 2020; 27(11-12): 382-386.
Web of Science

Führende Autor*innen der Med Uni Graz: Zirlik Andreas
Co-Autor*innen der Med Uni Graz: Schmidt Albrecht
Altmetrics:
Abstract:: Valvular heart disease of the mitral and tricuspid valve is responsible for a high morbidity and mortality of the affected patients. Surgical treatment carries a high perioperative risk which leads to an undertreatment of those patients. Transcatheter valve treatment represents a possibility to balance the mismatch between demand and supply for treatment of AV-pathologies. The landscape of transcatheter treatment includes interventional valve repair and interventional valve replacement. For interventional valve repair the techniques include edge-to-edge repair, direct and indirect annuloplasty and transapical chordae replacement. Evidence from randomized controlled trials indicate a prognostic benefit for selected patients. While interventional valve repair offers a high procedural safety, durability of the results seems to be inferior to surgical procedures. Possible solutions for this issue could be the combination of different interventional techniques or transcatheter valve replacement. The identification of patients who mostly benefit from the new therapeutic possibilities is the key challenge in the near future.
Find related publications in this database (Keywords): valvular heart disease; AV-valve disease; mitral valve intervention; tricuspid valve intervention